Peripartum cardiomyopathy is a form of systolic heart failure affecting young women toward
the end of pregnancy or in the months following delivery. Incidence is higher in African …

Peripartum cardiomyopathy is a potentially life-threatening pregnancy-associated disease
that typically arises in the peripartum period and is marked by left ventricular dysfunction and …

Peripartum cardiomyopathy (PPCM) is a rare, often dilated, cardiomyopathy with systolic
dysfunction that presents in late pregnancy or, more commonly, the early postpartum period …

Background Inotropes and vasopressors are frequently administered to critically ill patients
in order to improve haemodynamic function and restore adequate organ perfusion …

Heart disease continues to be the leading cause of nonobstetric maternal morbidity and
mortality. Early diagnosis and appropriate care can lead to prevention of complications and …

Peripartum cardiomyopathy is idiopathic heart failure occurring in the absence of any
determinable heart disease during the last month of pregnancy or the first 5 months …

Aims Persistence of left ventricular (LV) systolic dysfunction after 6 months of diagnosis is
believed to be a marker of an irreversible cardiomyopathy in peripartum cardiomyopathy …

Cardiomyopathies represent significant contributors to cardiovascular morbidity and
mortality. Over the past decades, a progress has occurred in characterization of the genetic …

Sepsis is a leading cause of maternal morbidity and mortality, globally and in the UK. In both
low-/middle-income countries (LMICs) and high-income countries (HICs), the incidence is …

Background Percutaneous mechanical circulatory support (MCS), such as the Impella heart
pump is a valuable option for cardiogenic shock (CS), although the use of Impella in CS due …